ADVERTISEMENT

Global Health IPO - Investment Rationale, Key Strategies, Strengths, Risks, Financials: Anand Rathi

Medanta have good operating metrics and financial profile with topline and margin increasing over years.

<div class="paragraphs"><p>Medanta hospital building. (Source: Company website).</p></div>
Medanta hospital building. (Source: Company website).

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

Anand Rathi's IPO Report

Global Health Ltd. operating under brand name 'Medanta' is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues.

It is recognised for clinical expertise in particular in dealing with complicated cases. The company has focus on under-served areas with dense population and presence in top or capital cities of large states (national capital region, Lucknow and Patna).

Global Health is available at the upper end of the IPO price band at 38.4 times its FY23 annualised earnings attributable to post issue equity demanding a market cap of Rs 90,110 million.

Global Health have good operating metrics and financial profile with topline and margin increasing over years. When compared to its listed peers, Medanta is fairly valued.

Click on the attachment to read the full IPO report:

Anand Rathi Global Health Ltd IPO Note.pdf

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.